Lv62
3160 积分 2021-08-30 加入
Preliminary Evaluation of Synthetic Amanitin Analogs as Novel Payloads for Potent Antibody−Drug Conjugates
2天前
已完结
Proposal on How To Conduct a Biopharmaceutical Process Failure Mode and Effect Analysis (FMEA) as a Risk Assessment Tool
5天前
已完结
PF-08046876, a Differentiated Integrin Beta-6 Antibody–Drug Conjugate Delivering a Potent Camptothecin Payload Optimized for Bystander Effect and Reduced Drug Efflux
5天前
已完结
Abstract 2138: ALG01, a next-generation anti-PD-L1×TROP-2 bispecific antibody-drug conjugate (BiADC) with STAR technology, demonstrated excellent anti-tumor efficacy & safety in preclinical studies
12天前
已完结
Ifinatamab Deruxtecan in Patients With Extensive-Stage Small Cell Lung Cancer: Primary Analysis of the Phase II IDeate-Lung01 Trial
12天前
已完结
Tambotatug Pelitecan in Small-Cell Lung Cancer after Platinum-Based Therapy
12天前
已完结
Antibody–Drug Conjugates (ADCs): current and future biopharmaceuticals
17天前
已完结
Bispecific antibody drug conjugates: Making 1+1>2
17天前
已完结
Linker Chemistry in Antibody–Drug Conjugates: Current Strategies, Clinical Pharmacokinetic Analyses, and Linker-Free Outlooks
18天前
已完结
Updated Recommendations for the Bioanalysis of Antibody–Drug Conjugates (ADC) from the ADC working group of the AAPS Bioanalytical Community
26天前
已完结
皖公网安备34019202002308
